Various health problems reported by people after receiving one of the COVID-19 vaccine shots are more likely to have been caused by the vaccines than to be coincidental, according to an analysis of data from the Vaccine Adverse Event Reporting System (VAERS).
In this interview, Alix Mayer explains why our children are being so aggressively targeted for the COVID-19 injection even though they’re not at risk of serious SARS-CoV-2 infection, and clarifies the status of Comirnaty.
Moderna plans to seek authorization for its pediatric COVID-19 vaccine for kids 6 and under, but experts say the vaccine maker’s trials for the young age group raise too many questions.
VAERS data released Friday by the Centers for Disease Control and Prevention included a total of 1,205,755 reports of adverse events from all age groups following COVID vaccines, including 26,396 deaths and 214,521 serious injuries between Dec. 14, 2020, and March 25, 2022.
A new peer-reviewed study shows more than two-thirds of adolescents with COVID-19 vaccine-related myopericarditis had persistent heart abnormalities months after their initial diagnosis, raising concerns for potential long-term effects and contradicting claims by health officials that the condition is “mild.”
“These are real people with real stories to share, and the more people who see them, the more awareness can grow to provide those who survived with the help and medical care they deserve — while warning others of the potentially deadly consequences of COVID-19 injections.”
Long COVID, also known as long-haul COVID, chronic COVID or long-haul syndrome, refers to symptoms that persist for four or more weeks after an initial COVID-19 infection. Board-certified internist and cardiologist Dr. Peter McCullough discusses potential treatments for long-haul COVID in the video above, including which tests may be necessary and when to seek emergency medical care.
Cardiologist, professor and frontline doctor Peter McCullough asserts that early COVID-19 testing data indicates the genetic materials in the vaccine could be incorporated into the human genome.
